As such, CCR7 agonists may bear therapeutic potential in PAH, yet this hypothesis remains to be tested in appropriate model systems. However, mRNA levels of CCL19 and CCL21, the ligands of CCR7, were not significantly different in lungs of patients
As such, CCR7 agonists may bear therapeutic potential in PAH, yet this hypothesis remains to be tested in appropriate model systems. However, mRNA levels of CCL19 and CCL21, the ligands of CCR7, were not significantly different in lungs of patients